Lung Cancer. With every breath you take, we’re here for you.

Lung cancer makes up 9% of all diagnosed cancers. That’s 9% too many. We don’t want to take your breath away – we want to give it back. 

Just like other cancers, lung cancer begins when abnormal cells grow and multiply in an uncontrolled way. This may occur in one, or both, of the lungs. The two main types of lung cancer are non-small cell lung cancer (NSCLC), and small cell lung cancer (SCLC)

Looking for how to help someone with lung cancer? At HealthMatch, we’re bringing forward tomorrow’s treatments. We have trials actively recruiting for lung cancer patients, including ones aimed at immunotherapy and targeting alterations in genes implicated in lung cancer.

Here at HealthMatch, we want to make sure everyone has a healthy set of lungs. Find a lung cancer clinical trial today. 

Explore clinical trials for lung cancer

Not yet open
NSCLC Clinical Trial
Not yet open
Heart Health Study
Not yet open
Help improve the clinical trial experience for NSCLC patients
Browse 100+ other trials on HealthMatch

Create an account and start answering some questions to see what trials match your profile.

1 in 5

cancer deaths in Australia are due to lung cancer¹

1 in 17

Australians will be diagnosed with lung cancer by their 85th birthday²


most common cancer diagnosis in Australia is lung cancer³

Why clinical trials?

Clinical trials are vital for researchers and physicians to advance modern medicine and improve the quality of life for future patients. All the drugs and medical equipment we use today are available because patients participated in clinical trials.

How do I apply for a trial?

Our platform helps you find the right match by showing you only trials you’re eligible for and simplifying the jargon. You’re then able to view matches and apply for trials in an easy-to-use dashboard. Once you’ve been accepted, we’ll put you in direct contract with the trial group.

If you don’t match with a clinical trial today, we won’t stop searching until we find the right match for you.

About HealthMatch
HealthMatch is an organisation driven by a mission to accelerate medical research allowing for faster and more efficient access to life-changing medication.

Our community consists of a diverse team of doctors, engineers, scientists, and people dedicated to challenging the status quo of medical research.

We are united by a passion to deliver better healthcare options, for all, regardless of location, background or means. This means access to trials and the revolutionary treatments that come from them.

Manuri GunawardenaFounder and CEO and HealthMatch


What is lung cancer?

Lung cancer may be primary, or secondary. Primary is where the cancer starts in the lung and secondary is where it starts elsewhere in the body and spreads to the lungs. 

There are two main groups of primary lung cancer. These are non-small cell lung cancer (NSCLC), and small cell lung cancer (SCLC). They are named for the size of the cancer cells when seen under a microscope.

NSCLC is the most common type, accounting for around 80-85% of cases. NSCLC has three main subtypes: squamous cell carcinoma, adenocarcinoma, and large cell carcinoma.

Squamous cell (epidermoid) carcinoma starts in the cells lining the airways of the lungs, usually close to the main windpipe.

Adenocarcinoma starts in the mucus-producing cells. These are in the deeper part of the lungs, away from the windpipe. It makes up about 40% of lung cancers.

Large cell (undifferentiated) carcinoma can appear in any part of the lung – however, they are not squamous cell or adenocarcinoma. 

What are the symptoms of lung cancer?

Common lung cancer symptoms include a new and persistent cough or a change in an ongoing cough; breathlessness; coughing up blood; chest pain and/or shoulder pain; a recurring chest infection that does not go away (ie. pneumonia or bronchitis), and more.

How do you treat lung cancer?

Treatment for lung cancer varies, depending on the type of cancer, the stage of cancer, lung function, and your general health. 

Early stages (I or II) of NSCLC are treated with surgery or radiation therapy.

The locally advanced stage (III) is treated with surgery and chemotherapy, or radiation therapy and chemotherapy.

The advanced stage (IV) is treated with palliative chemotherapy or palliative radiation therapy, depending on the symptoms.

SCLC is not treated with surgery. During early or locally advanced stages (I-III), chemotherapy and radiation therapy are used. 

For the advanced stage (IV), SCLC is mainly treated with palliative chemotherapy. 

Is there a cure for lung cancer?

For early or localled advanced lung cancers, curative treatments such as chemotherapy and targeted therapy, may be given with the aim of removing all signs and symptions of the cancer.

However, as lung cancer causes vague symptoms in the early stages, many people are diagnosed only when the cancer is in an advanced stage. At this stage, cancer has spread outside the lung to other parts of the body. Treatment at this stage is focused on slowing down the spread of cancer and managing any symptoms as no cure is currently available.

Researchers are constantly searching for better treatments and potential cures. HealthMatch helps you find potential clinical trials you can contribute to today.

1, 3 Cancer Council, About Lung Cancer

Australian Government Cancer Australia, Lung Cancer in Australia Statistics